Optimizing Neurocysticercosis Care: Pharmacotherapy, Surgery, and Monitoring

Article Sidebar

PDF
Published: Dec 11, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i12-15
Keywords:
Neurocysticercosis, Taenia solium, anthelmintic therapy, corticosteroids, surgical interventions, pregnancy considerations, monitoring, antiepileptic management.

Main Article Content

Isabel Soto Angulo
IMSS Hospital General de Zona no. 5, Nogales, Sonora.
Jesús Salvador Valdez García
IMSS Hospital General de Zona no. 5, Nogales, Sonora.

Abstract

Neurocysticercosis, caused by Taenia solium larval invasion of the central nervous system, demands a nuanced approach. Treatment involves corticosteroids (dexamethasone, prednisolone, prednisone) and antiparasitic agents (albendazole, praziquantel), tailored to lesion characteristics. Surgical interventions may be necessary. Pregnancy requires anthelmintic therapy deferment. Vigilant monitoring, weaning off antiepileptics, and managing corticosteroid side effects are crucial. This concise overview navigates the intricate landscape of neurocysticercosis management for optimal patient outcomes.

Article Details

How to Cite
Isabel Soto Angulo, & Jesús Salvador Valdez García. (2023). Optimizing Neurocysticercosis Care: Pharmacotherapy, Surgery, and Monitoring. International Journal of Medical Science and Clinical Research Studies, 3(12), 3007–3009. https://doi.org/10.47191/ijmscrs/v3-i12-15
Issue
Vol. 3 No. 12 (2023): Volume 03 Issue 12 December 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Dixon, M. A., Winskill, P., Harrison, W. E., & Basáñez, M. G. (2021). Taenia solium taeniasis/cysticercosis: from parasite biology and immunology to diagnosis and control. Advances in Parasitology, 112, 133-217.

II. Shongwe, N. A., Byaruhanga, C., Dorny, P., Dermauw, V., & Qekwana, D. N. (2020). Knowledge, practices and seroprevalence of Taenia species in smallholder farms in Gauteng, South Africa. Plos one, 15(12), e0244055.

III. ANADURE, R. K., WILSON, V., Saxena, R., MOHIMEN, A., SIVASANKAR, R., & ABHISHEKA, K. (2020). A Multicentric Study on the Clinical Profile, Serology, Neuroimaging and Treatment of Neurocysticercosis. Journal of Clinical & Diagnostic Research, 14(10).

IV. Mulilo, M. A., Mwape, K. E., M’kandawire, E., & Mkupasi, E. M. (2023). Quantitative risk assessment for human Taenia solium taeniasis/cysticercosis exposure through consumption of pork in Mpwapwa District of Dodoma Region, Tanzania. Veterinary World, 16(5), 895.

V. Butala, C., Brook, T. M., Majekodunmi, A. O., & Welburn, S. C. (2021). Neurocysticercosis: current perspectives on diagnosis and management. Frontiers in Veterinary Science, 8, 615703.

VI. Coyle, C. M. (2021). The returned traveler with neurologic manifestations: could my patient have a parasite?. Current Opinion in Infectious Diseases, 34(3), 245-254.

VII. Asín, M. A. P. J., Calleja-Castaño, P., & Hilario, A. (2020). Lumbosacral radiculopathy as the clinical presentation of neurocysticercosis. The American Journal of Tropical Medicine and Hygiene, 102(6), 1166.

VIII. Osorio, R., Carrillo‐Mezo, R., Romo, M. L., Toledo, A., Matus, C., González‐Hernández, I., ... & Fleury, A. (2019). Factors associated with cysticidal treatment response in extraparenchymal neurocysticercosis. The Journal of Clinical Pharmacology, 59(4), 548-556.

IX. Hamamoto Filho, P. T., Rodríguez-Rivas, R., & Fleury, A. (2022). Neurocysticercosis: A Review into Treatment Options, Indications, and Their Efficacy. Research and Reports in Tropical Medicine, 67-79.

X. Zymberg, S. T. (2013). Neurocysticercosis. World Neurosurgery, 79(2), S24-e5.

XI. Bradley, M., & Horton, J. (2001). Assessing the risk of benzimidazole therapy during pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95(1), 72-73.